Primary Care
Farxiga Samples for Healthcare Providers
Explore medication sample resources and treatment access support for clinicians prescribing Farxiga® (dapagliflozin tablets).
Farxiga® (dapagliflozin) is an SGLT2 inhibitor indicated for adults with type 2 diabetes mellitus and certain heart failure and chronic kidney disease populations. It is administered as an oral tablet and may be prescribed to support glycemic, cardiovascular, and renal treatment goals in appropriate patients. Farxiga® is commonly used across endocrinology, cardiology, and nephrology care settings.
Built to help reduce friction around treatment access & patient care.
Request Farxiga® (dapagliflozin tablets) sample support and treatment access assistance through DocUpdate Concierge.
Request Samples Through DocUpdate
DocUpdate provides free HIPAA-compliant mobile tools that move care forward.
Frequently Asked Questions About Farxiga Samples
Healthcare providers can download the DocUpdate app and submit a request through Concierge for medication sample and treatment access support.
Farxiga is an oral SGLT2 inhibitor that helps reduce glucose reabsorption and has indications across cardiometabolic and renal care.
Farxiga may be used for glycemic control in type 2 diabetes and for selected patients with heart failure or chronic kidney disease.
DocUpdate is designed for licensed healthcare providers with an active NPI number, including physicians, nurse practitioners, and physician assistants.
No. DocUpdate does not dispense medications or provide direct medication fulfillment. The platform helps healthcare providers navigate medication sample support and treatment access resources through Concierge.
Yes. DocUpdate provides free HIPAA-compliant tools and support resources for healthcare providers.